Oncotarget

Research Papers:

The sphingosine kinase 2 inhibitor ABC294640 inhibits cervical carcinoma cell growth

Ling Xu, Longmei Jin, Baohua Yang, Lifeng Wang, Ziyin Xia, Qian Zhang and Jun Xu _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:2384-2394. https://doi.org/10.18632/oncotarget.23415

Metrics: PDF 412 views  |   HTML 819 views  |   ?  


Abstract

Ling Xu1,*, Longmei Jin2,*, Baohua Yang1,*, Lifeng Wang1, Ziyin Xia1, Qian Zhang3 and Jun Xu1

1Department of Obstetrics and Gynecology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China

2Minhang District Maternal and Child Health Hospital, Shanghai, China

3Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, China

*Co-first authors

Correspondence to:

Jun Xu, email: xujunminh81@163.com

Qian Zhang, email: qzhangfud75@163.com

Keywords: cervical carcinoma; sphingosine kinase 2; ABC294640; Bcl-2; ceramide

Received: October 26, 2017    Accepted: December 05, 2017    Published: December 19, 2017

ABSTRACT

ABC294640 is a specific sphingosine kinase 2 (SphK2) inhibitor. The anti-cervical carcinoma activity by ABC294640 was tested in this study. ABC294640 inhibited in vitro growth of the established (C33A and HeLa lines) and primary human cervical carcinoma cells. The SphK2 inhibitor also induced G1-S arrest and apoptosis in cervical carcinoma cells. It was yet non-cytotoxic to SphK2-low human cervical epithelial cells. ABC294640 inhibited SphK activation, causing sphingosine-1-phosphate depletion, signal transducer and activator of transcription 3 in-activation and ceramide production. Bcl-2 is a key resistance factor of ABC294640. Pharmacological Bcl-2 inhibition or Bcl-2 shRNA potentiated ABC294640-induced C33A cell growth inhibition and apoptosis. On the other hand, exogenous over-expression of Bcl-2 attenuated ABC294640’s cytotoxicity against C33A cells. In vivo, ABC294640 administration inhibited C33A xenograft tumor growth in mice. Co-administration of the Bcl-2 inhibitor GDC-0199 further potentiated ABC294640’s anti-tumor activity. Together, we suggest that ABC294640 might have translational value for the treatment of human cervical carcinoma.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 23415